1. Home
  2. IOTR vs FGEN Comparison

IOTR vs FGEN Comparison

Compare IOTR & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOTR
  • FGEN
  • Stock Information
  • Founded
  • IOTR 2019
  • FGEN 1993
  • Country
  • IOTR Singapore
  • FGEN United States
  • Employees
  • IOTR N/A
  • FGEN N/A
  • Industry
  • IOTR
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IOTR
  • FGEN Health Care
  • Exchange
  • IOTR NYSE
  • FGEN Nasdaq
  • Market Cap
  • IOTR 11.5M
  • FGEN 33.5M
  • IPO Year
  • IOTR 2025
  • FGEN 2014
  • Fundamental
  • Price
  • IOTR $0.47
  • FGEN $7.03
  • Analyst Decision
  • IOTR
  • FGEN Strong Buy
  • Analyst Count
  • IOTR 0
  • FGEN 1
  • Target Price
  • IOTR N/A
  • FGEN $250.00
  • AVG Volume (30 Days)
  • IOTR 693.0K
  • FGEN 43.0K
  • Earning Date
  • IOTR 01-01-0001
  • FGEN 08-12-2025
  • Dividend Yield
  • IOTR N/A
  • FGEN N/A
  • EPS Growth
  • IOTR N/A
  • FGEN N/A
  • EPS
  • IOTR N/A
  • FGEN N/A
  • Revenue
  • IOTR $10,478,550.00
  • FGEN $6,996,000.00
  • Revenue This Year
  • IOTR N/A
  • FGEN N/A
  • Revenue Next Year
  • IOTR N/A
  • FGEN N/A
  • P/E Ratio
  • IOTR N/A
  • FGEN N/A
  • Revenue Growth
  • IOTR 22.27
  • FGEN N/A
  • 52 Week Low
  • IOTR $0.31
  • FGEN $4.50
  • 52 Week High
  • IOTR $5.98
  • FGEN $29.00
  • Technical
  • Relative Strength Index (RSI)
  • IOTR N/A
  • FGEN 50.17
  • Support Level
  • IOTR N/A
  • FGEN $7.04
  • Resistance Level
  • IOTR N/A
  • FGEN $7.56
  • Average True Range (ATR)
  • IOTR 0.00
  • FGEN 0.49
  • MACD
  • IOTR 0.00
  • FGEN -0.00
  • Stochastic Oscillator
  • IOTR 0.00
  • FGEN 12.53

About IOTR IOTHREE LIMITED

iOThree Ltd is a provider of maritime digital technologies, including satellite connectivity and digitalization solutions in Singapore, focused on facilitating the maritime industry towards digital transformation. It offers shipboard infrastructure to customers by designing and installing the necessary satellite connectivity solution, IT equipment, shipboard equipment (such as equipment relating to navigation systems, automatic identification system, etc.), and JARVISS, a digitalization platform on the vessels of customers. The group's operating segments are: Satellite connectivity solution, which generates key revenue, and Digitalization and other solution. Geographically, it generates maximum revenue from Singapore, and rest from Israel, Malaysia, Vietnam, Thailand, and other regions.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: